Life‐threatening human parvovirus B19 infection transmitted by intravenous immune globulin
暂无分享,去创建一个
[1] T. Weimer,et al. High‐titer screening PCR: a successful strategy for reducing the parvovirus B19 load in plasma pools for fractionation , 2001, Transfusion.
[2] Takayuki Takubo,et al. Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery , 2000, British journal of haematology.
[3] L. Anderson,et al. Possible transmission of parvovirus B19 from intravenous immune globulin , 1997, Journal of medical virology.
[4] C. Prowse,et al. Human Parvovirus B19 and Blood Products , 1997, Vox sanguinis.
[5] J. Saldanha,et al. Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufacture , 1996, British journal of haematology.
[6] R. Markin,et al. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia , 1995, Hepatology.
[7] N. Young,et al. Chronic bone marrow failure due to persistent B19 parvovirus infection. , 1987, The New England journal of medicine.
[8] M. Anderson,et al. Experimental parvoviral infection in humans. , 1985, The Journal of infectious diseases.
[9] J. Clewley,et al. INTRAUTERINE PARVOVIRUS INFECTION ASSOCIATED WITH HYDROPS FETALIS , 1984, The Lancet.
[10] P. Mortimer,et al. TRANSMISSION OF SERUM PARVOVIRUS-LIKE VIRUS BY CLOTTING-FACTOR CONCENTRATES , 1983, The Lancet.
[11] R. Lau. Coxsackie B virus infections in new zealand patients with cardiac and non‐cardiac diseases , 1983, Journal of medical virology.
[12] S. Jones,et al. PARVOVIRUS INFECTIONS AND HYPOPLASTIC CRISIS IN SICKLE-CELL ANAEMIA , 1981, The Lancet.
[13] C. S. Jones. REGIONAL CURARISATION. ANAESTHESIA FOR SURGERY OF THE KNEE-JOINT. , 1963, Lancet.